Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway
Open Access
- 1 November 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (45), 44608-44616
- https://doi.org/10.1074/jbc.m307435200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast CancerCell, 2003
- DNA Methylation Down-regulates CDX1 Gene Expression in Colorectal Cancer Cell LinesPublished by Elsevier BV ,2002
- Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the ColonThe American Journal of Pathology, 2001
- PTEN and Myotubularin: Novel Phosphoinositide PhosphatasesAnnual Review of Biochemistry, 2001
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature, 2000
- Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elementsOncogene, 1999
- CDX2 is mutated in a colorectal cancer with normal APC/β-catenin signalingOncogene, 1999
- CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancerOncogene, 1998
- Cloning and chromosome assignment of the human CDX2 geneAnnals of Human Genetics, 1997
- Cloning and chromosome assignment of the human CDX2 geneAnnals of Human Genetics, 1997